References
- Franks S. Medical progress: polycystic ovary syn-drome. N Engl J Med 1995;333:853–61
- Dunaif A, Segal KR, Futterweit W, et al. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989;38: 1165–74
- Holte J. Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style? J Endocrinol Invest 1998;21: 589–601
- Bringer J, Lefebvre P, Boulet F, et al. Body composition and regional fat distribution in poly-cystic ovarian syndrome. Relationship to hormonal and metabolic profiles. Anna NY Acad Sci 1993;687: 115–23
- McCluskey SE, Evans C, Lacey JH, et al. Polycystic ovary syndrome and bulimia. Fertil Steril 1991;55:287–91
- Jahanfar S, Eden JA, Nguyent TV. Bulimia nervosa and polycystic ovary syndrome. Gynecol Endocrinol 1995;9:113–17
- Morgan JF, McCluskey SE, Brunton JN, et al. Polycystic ovarian morphology and bulimia ner-vosa: a 9-year follow-up study. Fertil Steril 2002;77:928–31
- Mutt V. Secretin and cholecystokinin. In Mutt V, ed. Advances in Metabolic Disorders: Gastrointestinal Hormones II. San Diego: Academic Press, 1988;11:270–320
- Grider JR. Role of cholecystokinin in the regulation of gastrointestinal motility. J Nutr 1994;124:1334S–9S
- Niederau C, Luthen R, Heintges T. Effects of CCK on pancreatic function and morphology. Ann NY Acad Sci 1994;713:180–98
- Gibbs J, Smith GP. Satiating effect of cholecysto-kinin. Ann NY Acad Sci 1994;23:236–41
- Linden A. Role of cholecystokinin in feeding and lactation. Acta Physiol Scand 1989;137(Suppl):1–49
- Linden Hirschberg A, Lindholm C, Carlström K, et al. Reduced serum cholecystokinin response to food intake in female athletes. Metabolism 1994;43:217–22
- Geracioti TD Jr, Liddle RA. Impaired cholecysto-kinin secretion in bulimia nervosa. N Engl JMed 1988;319:683–8
- Philipp E, Pirke KM, Kellner MB, et al. Disturbed cholecystokinin secretion in patients with eating disorders. Life Sci 1991;48:2443–50
- Karlsson R, Linden A, von Schoultz B. Suppression of 24-hour cholecystokinin secretion by oral contra-ceptives. Am J Obstet Gynecol 1992;167:58–9
- Linden Hirschberg A, Byström B, Carlström K, et al. Reduced serum cholecystokinin and increase in body fat during oral contraception. Contraception 1996;53:109–13
- Holte J. Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Bailliere's Clin Endocrinol Metab 1996;10:221–47
- Ciampelli M, Fulghesu AM, Cucinelli F, et al. Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod 1997;12:1897–901
- Prelevic GM, Wurzburger MI, Balint-Peric L, et al. Twenty-four hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in wo-men with polycystic ovaries. Horm Res 1992;37:125–31
- Gennarelli G, Holte J, Stridsberg M, et al. The counterregulatory response to hypoglycemia in women with the polycystic ovary syndrome. Clin Endocrinol 1997;46:167–74
- Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986;293:355–9
- Södergard R, Bäckström T, Shanbag V, et al. Calculation of free and bound fractions of testoster-one and estradio1-17fi to plasma proteins at body temperature. J Steroid Biochem 1982;18:801–4
- Devlin MJ, Walsh BT, Guss JL, et al. Postprandial cholecystokinin release and gastric emptying in patients with bulimia nervosa. Am J Clin Nutr 1997;65:114–20
- Horowitz M, Fraser R. Disordered gastric motor function in diabetes mellitus. Diabetologia 1993;36:857–62
- Earley CJ, Leonard BE. Androgens, estrogens and their anti-hormones: effects on body weight and food consumption. Pharmacol Biochem Behav 1979;11:211–4
- Mooradian AD, Morley JE, Korenman SG. Biolo-gical actions of androgens. Endocr Rev 1987;8:1–28
- Geary N. Estradiol, CCK and satiation. Peptides 2001;22:1251–63.